“Our study opened the question whether temporarily restricting Na intake and possibly also preventing Na production by the gut microbial flora (e.g., by antibiotics), could be a viable strategy to increase the activity of NAMPT inhibitors, chemotherapeutics, and of PARP inhibitors.”